Protecting muscle while you lose fat

Any weight loss can cost lean mass if you let it. Protein and resistance training are how you steer the loss toward fat.

V

By The Vive Team

July 2026 · 7 min read

When you lose weight — by any method — some of what you lose can be lean tissue, including muscle, not just fat. This is a feature of weight loss in general, not something unique to GLP-1 medicines. The good news is that it is largely within your control.

Why muscle matters

Muscle is not just about strength or appearance. It supports your metabolism, your balance and mobility as you age, and your ability to keep weight off later. Losing a large share of muscle during weight loss can make maintenance harder down the line — so protecting it is a long-term investment, not vanity.

The two levers that work

Two things reliably shift the balance of loss toward fat and away from muscle:

  • Adequate protein. Spreading enough protein across your meals gives your body the raw material to preserve muscle in a calorie deficit. On GLP-1 therapy, appetite is lower — so protein has to be deliberate, because it is easy to under-eat it.
  • Resistance training. Lifting, bands, or bodyweight work a few times a week is the single strongest signal telling your body to hold on to muscle while fat comes off.

GLP-1s make this more important, not less

Because appetite drops, some people on GLP-1 therapy drift into eating too little of everything, protein included. A little planning — a protein-forward breakfast, not skipping meals entirely — goes a long way. Your care team and our free nutrition tools can help you set sensible targets.

The takeaway

The goal was never simply a smaller number on the scale — it was a healthier body composition. Protein plus resistance training is how you make sure the weight you lose is the weight you meant to lose.

// References

  1. 1.Clinical guidance on protein intake and resistance exercise during intentional weight loss to preserve lean mass (obesity-management consensus literature).
  2. 2.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205–216. View study →

Provided for education only. Trial averages describe study populations, not any individual’s expected result. This is not medical advice — GLP-1 medication is prescription-only and outcomes vary.

Medically reviewed by Vive’s licensed physicians. Meet the clinicians →

Curious what’s right for you?

Take the 3-min quiz →